In this study, several simple equations are suggested to investigate the effects of size and density on the number, surface area, stiffening efficiency, and specific surface area of nanoparticles in polymer nanocomposites. In addition, the roles of nanoparticle size and interphase thickness in the interfacial/interphase properties and tensile strength of nanocomposites are explained by various equations. The aggregates/agglomerates of nanoparticles are also assumed as large particles in nanocomposites, and their influences on the nanoparticle characteristics, interface/interphase properties, and tensile strength are discussed. The small size advantageously affects the number, surface area, stiffening efficiency, and specific surface area of nanoparticles. Only 2 g of isolated and well-dispersed nanoparticles with radius of 10 nm (R = 10 nm) and density of 2 g/cm3 produce the significant interfacial area of 250 m2 with polymer matrix. Moreover, only a thick interphase cannot produce high interfacial/interphase parameters and significant mechanical properties in nanocomposites because the filler size and aggregates/agglomerates also control these terms. It is found that a thick interphase (t = 25 nm) surrounding the big nanoparticles (R = 50 nm) only improves the B interphase parameter to about 4, while B = 13 is obtained by the smallest nanoparticles and the thickest interphase.
Objective To determine whether pre-treatment with high-dose ulinastatin provides enhanced postoperative oxygenation in patients who have undergone aortic valve surgery with moderate hypothermic cardiopulmonary bypass (CPB). Methods Patients who underwent aortic valve surgery with moderate hypothermic CPB were retrospectively evaluated. In total, 94 of 146 patients were included. The patients were classified into one of two groups: patients in whom ulinastatin (10,000 U/kg followed by 5,000 U/kg/h) was administered during CPB (Group U, n = 38) and patients in whom ulinastatin was not administered (Group C, n = 56). The PaO2/FiO2 ratio was calculated at the following time points: before CPB (pre-CPB), 2 h after weaning from CPB (post-CPB), and 6 h after arrival to the intensive care unit (ICU-6). The incidence of a low PaO2/FiO2 ratio was also compared among the time points. Results Group U showed a significantly higher PaO2/FiO2 ratio (F(4, 89.0) = 657.339) and a lower incidence of lung injury (PaO2/FiO2 ratio